Victor Anggono received his PhD in 2007 from the University of Sydney and undertook his postdoctoral training at the Johns Hopkins University in Baltimore, USA. In 2012, Dr Anggono returned to Australia as an NHMRC CJ Martin Research Fellow and joined the Queensland Brain Institute at the University of Queensland, where he is currently a Senior Research Fellow and Group Leader at the Clem Jones Centre for Ageing Dementia Research. His research aims to understand the molecular mechanisms of synaptic vesicle and glutamate receptor trafficking in neurons, processes that are essential for synaptic transmission, plasticity, learning and memory, and how their dysregulations impact on the pathophysiology of neurodegenerative diseases and neuropsychiatric disorders. Dr Anggono has published in journals such as Nature Neuroscience, Neuron, The Proceedings of the National Academy of Sciences USA, Journal of Neuroscience and Cell Reports, and has attracted more than 1500 citations. For his works, Dr Anggono was awarded the Boomerang Award (Australian Society for Biochemistry and Molecular Biology, 2011), the Young Scientist Award (Federation of Asian and Oceanian Biochemists and Molecular Biologists, 2015), the Science to Art Award (NHMRC, 2015) and more recently the Young Investigator Award (Asian-Pacific Society for Neurochemistry, 2016).

Dr. Matilde Balbi is a neuroscientist within the Queensland Brain Institute, The University of Queensland. After receiving her bachelor and master's degree in Medical Biotechnology from the University of Naples,Italy, she spent a year working on traumatic brain injury at the Royal College of Surgeons in Ireland as a research assistant. Dr. Balbi earned her Ph.D. in Neuroscience at the Ludwig Maximilians University in Munich, Germany, working on the regulation of cerebral blood flow in health (ageing) and disease (small vessel disease and subarachnoid haemorrhage). She completed her postdoctoral training at the University of British Columbia in Vancouver, Canada, where she received support and fellowships from the Leducq Foundation, CPSR, MSFHR. She now leads her laboratory which aims to make an impact on the field of stroke recovery and other pathological conditions by combining imaging techniques, brain stimulation and individually tailored recovery paradigms in behaving rodents.

Research in the Bredy laboratory is aimed at elucidating how the genome is connected to the environment through epigenetic modifications, and how this relationship shapes brain and behaviour throughout life. The group is particularly interested in how epigenetic mechanisms, including DNA methylation, histone modifications. the activity of non-coding RNAs, and RNA modification regulate the formation and maintenance of associative fear-related memory.

Professor Burne is a leading Australian researcher in the field of biological psychiatry. Prof. Burne has >150 peer reviewed publications, which have attracted over 8500 citations (H-index 50). His research impact is evident by his 11 papers with >200 citations, with two recognised as Web of Science 'Highly Cited Papers'. Together with collaborators he has been awarded >$8 million in research funding. Since 2003 he has supervised 17 PhD students, and 28 honours students Prof. Burne has a broad background in behavioural neuroscience, with specific training and expertise in animal models. As a Professorial Research Fellow with the Queensland Centre for Mental Health Research and Group Leader at the Queensland Brain Institute (QBI) the focus of his research includes cognitive testing in rodent models of neuropsychiatric disorders, such as schizophrenia, as well as psychopharmacological studies and research on clinical populations. As a CI on several university- and NHMRC-funded grants, he has helped establish infrastructure at QBI for behavioural assessment and methods of automated operant-based cognitive tests in rodents. Prof. Burne is a past president of Biological Psychiatry Australia, he is the Queensland representative for the Australasian Neuroscience Society, and he is a member of the NHMRC Animal Welfare Committee.

Prof. Burne's group studies brain development and behaviour in animal models to learn more about neuropsychiatric diseases, such as schizophrenia. Research is focused on investigating the underlying biological basis for schizophrenia, with the goal of finding public health interventions that will alleviate the burden of this disease. The group has been exploring the impact of developmental vitamin D (DVD) deficiency on brain development, the impact of adult vitamin D deficiency on brain function and behaviour, and the neurobiological affects of having an older father. More recently his group has been focussed on assessing cognitive function in rodents. Prof. Burne's research is carried out in close collaboration with Professors John McGrath and Darryl Eyles, in a multidisciplinary team. Together they have an integrated research program using a broad range of neuroscientific techniques to explore potential causes of schizophrenia. There is a particular focus on early life, nongenetic risk factors and the team has skills in epidemiology, psychiatry, neuroanatomy, molecular biology, developmental biology and behavioural neuroscience. The Burne group is currently developing animal models related to risk factors for schizophrenia and autism.

Professor Elizabeth (Lizzie) Coulson did her undergraduate Honours degree at the University of Melbourne, majoring in Genetics and Biochemistry. Her PhD (1997) in the Department of Pathology, University of Melbourne, with Professor Colin Masters, was on the normal function of the amyloid precursor protein of Alzheimer's disease. Following a year at the ZMBH, University of Heidelberg, Germany, she pursued postdoctoral work studying neuronal cell death in neurodegeneration and development at the Walter and Eliza Hall Institute with Professor Perry Bartlett before being recruited in 2003 to the University of Queensland as a founding member of the Queensland Brain Institute. She was appointed Professor in 2015, joining the School of Biomedical Sciences and becoming Deputy Head of School in 2016/7 and 2019 and Head of School in 2020. She maintains a 20% Queensland Brain Institutes appointment and is a member of the Clem Jones Centre for Ageing Dementia Research.

Her Lab webpage is: Coulson Lab - Neurotrophin - School of Biomedical Sciences ...

Prof Darryl Eyles is the head of the Queensland Centre for Mental Health Research Developmental Neurobiology laboratory. One of Darryl's research directions is focused on how known risk-factors for schizophrenia change the way the brain develops. His group have established the biological plausibility of various epidemiological risk factors for this disease including developmental vitamin D deficiency, prenatal hypoxia and maternal immune activation. Strikingly all these exposures affect the early development and later differentiation of early dopamine neurons. A second major focus is on understanding the effects of increased dopamine release in selective circuits and how this may be causal in schizophrenia. A third major interest is in factors such as the gut microbiome, and how increased testosterone contribute to altered brain function related to autism.

Professor Jürgen Götz (PhD, Dr. habil, FAHMS, GAICD) is Foundation Chair of Dementia Research, Director of the Clem Jones Centre for Ageing Dementia Research at the Queensland Brain Institute (University of Queensland), NHMRC Leadership Fellow and Ultrasound Team Leader. In 2023 he became the Lesleigh Green - Bill and Nancy Green Endowed Chair in Dementia Research. Jürgen Götz performed undergraduate studies at the Biocenter of the University of Basel, before joining the laboratory of Nobel Laureate Georges Köhler to obtain his PhD degree in immunology. Subsequently, he took up postdoctoral positions at UCSF (San Francisco) and Sandoz Ltd (now Novartis, Basel), and worked as Research Group Leader (venia legendi, Dr. habil.) at the University of Zurich (Switzerland). Before taking up his current position, Jürgen Götz was a Professor and Chair of Molecular Biology at the University of Sydney.

Jürgen Götz is a highly cited researcher (Clarivate) and an expert in basic and translational research in Alzheimer's disease (AD), focusing on the cellular and molecular mechanisms of how Tau and Aβ cause neurodegeneration, using transgenic and cellular models, and exploring low-intensity ultrasound as a novel treatment modality for AD and other brain diseases (>220 publications, including in leading journals such as Science, Cell, Lancet and Neuron; h-index = 86, 27,800+ citations, Google Scholar). Jürgen Götz and his team have built a clinical trial-ready therapeutic ultrasound device and started a first-in-human safety trial in 12 Alzheimer patients (April 2023).

Queensland Brain Institute

Dr Massimo A. Hilliard received his PhD in Biological Chemistry and Molecular Biology in 2001 from the University of Naples, Italy. His experimental work, performed at the Institute of Genetics and Biophysics of the CNR (Italian National Council of Research), was aimed at understanding the neuronal and genetic basis of aversive taste behavior (bitter taste) in C. elegans.

During his first postdoc at the University of California, San Diego, using the Ca2+ indicator Cameleon he published the first direct visualisation of chemosensory activity in C. elegans neurons. In his second postdoctoral work at the University of California, San Francisco and at The Rockefeller University, he switched from neuronal function to neuronal development, focusing in particular on how neurons establish and orient their polarity with respect to extracellular cues.

From September 2007, he is at the Queensland Brain Institute where he established an independent laboratory.

Dr Dhanisha Jhaveri has a joint appointment at Mater Research and the Queensland Brain Institute (QBI) and is a Mater Foundation Senior Research Fellow and a Group Leader. Dhanisha's research group is investigating the fundamental mechanisms that drive the renewal of neurons in the adult brain, with the goal of harnessing this form of neural plasticity to relieve the emotional and cognitive burdens associated with chronic stress and depression.

Dhanisha received her PhD from the Tata Institute of Fundamental Research (TIFR), India, under the supervision of Professor Veronica Rodrigues, where she unravelled the molecular mechanisms that wire the olfactory axons in the fly (Drosophila) brain. In recognition of her doctoral work she was awarded the Indian National Science Academy medal for Young Scientist of the Year in 2003. Fascinated by the discovery that the production of new neurons continues in the adult brain, she then joined the laboratory of Professor Perry Bartlett at the Queensland Brain Institute as a Human Frontiers Science Program Postdoctoral Fellow. She has made major discoveries that have transformed our understanding of the regulation and roles of neural stem cells in the adult brain. Her work uncovered that a subclass clinical antidepressants directly activates neural stem cells in the hippocampus, a brain region implicated in regulating mood and cognitive functions. She also pioneered the development of a new cell sorting protocol to purify neural stem cells which revealed presence of distinct stem cell populations in this brain region.

Professor Jason Mattingley was appointed as Foundation Chair in Cognitive Neuroscience at the University of Queensland in January 2007, a joint appointment between the Queensland Brain Institute and the School of Psychology.

He completed a Bachelor of Science Degree with Honours at Monash University (1988), a Master of Science Degree in Clinical Neuropsychology at the University of Melbourne (1990), and a PhD in Psychology at Monash University (1995). In 1994 he was awarded an NHMRC Neil Hamilton Fairley Post-Doctoral Fellowship, which he took to the University of Cambridge. Here he worked jointly with Professor Jon Driver in the Department of Experimental Psychology and Professor Ian Robertson at the MRC Cognition and Brain Sciences Unit. While in Cambridge he was elected a Fellow of King's College.

Upon returning to Australia Professor Mattingley was appointed as Senior Research Fellow (later Principal Research Fellow) at the University of Melbourne, where he was Director of the Cognitive Neuroscience Laboratory within the School of Behavioural Science (2000 – 2006).

Professor Mattingley has won numerous accolades for his research, including an Australian Laureate Fellowship from the Australian Research Council (2012), the Distinguished Contribution to Psychological Science Award from the Australian Psychological Society (2012), and the Monash University Distinguished Alumni Award (Faculty of Biomedical and Psychological Sciences, 2016).

He was elected a Fellow of the Academy of Social Sciences in Australia in 2007, and a Fellow of the Association for Psychological Science in 2016.

John McGrath AM, MBBS, MD, PhD, FRANZCP, FAHMS

John McGrath is a psychiatrist interested in discovering the causes of serious mental disorders. He is the Director of the Queensland Centre for Mental Health Research and conjoint Professor at the Queensland Brain Institute His research aims to generate and evaluate nongenetic risk factors for schizophrenia. He has forged productive cross-disciplinary collaborations linking risk factor epidemiology with developmental neurobiology. For example, John and his colleagues have made discoveries linking prenatal vitamin D and later risk of mental illness in the offspring. In addition, John has supervised major systematic reviews of the epidemiology of schizophrenia. He was awarded a John Cade Fellowship by the Australian National Health and Medical Research Council. In 2016 he was also awarded a Neils Bohr Professorship by the Danish National Research Foundation.

Professor Frederic Meunier obtained his Masters degree in Neurophysiology at the Paris XI University, France in 1992 and completed his Ph.D in Neurobiology at the CNRS in Gif-sur-Yvette, France in 1996. He was the recipient of a European Biotechnology Fellowship and went on to postgraduate work at the Department of Biochemistry at Imperial College (1997-1999) and at Cancer Research UK (2000-2002) in London, UK. After a short sabbatical at the LMB-MRC in Cambridge (UK), he became a group leader at the School of Biomedical Sciences at the University of Queensland (Australia) in 2003. He joined the Queensland Brain Institute of the University of Queensland in 2007 and obtained an NHMRC senior research fellowship in 2009 renewed in 2014 with promotion. He became Professor in 2014 at the Queensland Brain Institute and is currently part of the Centre for Ageing Dementia Research.

Bryan is a graduate in medicine from the University of Queensland and holds a BA (Hons) degree in philosophy from the University of Western Australia. A medical specialist in psychiatry, he is a clinician researcher, who is Conjoint Professor at the Queensland Brain Institute, University of Queensland, and Director of Genetics at the Queensland Centre for Mental Health Research. His primary research interest is the molecular genetics of schizophrenia, and holds a MD degree (University of Queensland) in this field. Since 1990, he has conducted studies, with national and international collaborators, to identify susceptibility genes for this disorder. He is the recipient of grants from the Australian NHMRC and the US NIMH.

The primary research goal is to identify and functionally characterise susceptibility genes for schizophrenia and related disorders. A special focus is on the study of large collaborative samples and ethnically homogeneous populations. Key methodologies used in the lab include genome-wide association studies, next-generation sequencing, transcriptome profiling of post-mortem brain samples, neurocognitive and neuroimaging phenotyping and induced pluripotent stem cells.

Current areas of interest include pharmacogenomics of clozapine treatment response, whole exome sequencing focused on de novo mutations, and the neuroimmunology of schizophrenia

Dr. Nasrallah is a neuroscientist with a background in magnetic resonance and interdisciplinary brain research. She graduated with a PhD in neurochemistry and NMR from the Neuroscience Research Australia Institute (NeurRA) at the University of New South Wales in 2009. In April 2009, She spent 3 years at the Singapore Bioimaging Consortium (A*STAR) where she pioneered the use of magnetic resonance imaging as a tool in cognitive brain research in the rodent. In 2013, she was appointed as senior research fellow at the Clinical Imaging Research Center where she delved into the clinical realms of human imaging. In late 2015, she returned to Australia as a Motor Accident and Injury Commission fellow at the Queensland Brain Institute (QBI) at the University of Queensland (UQ) where she independently heads her own group. Her research spans basic and clinical brain research with the the overall aim of understanding how the brain functions in health and injury, specifically, developing methods for early diagnosis of primary biomarkers following injury and translating these findings.

Prof Nestor joined the Queensland Brain Institute in October/2017 and has a conjoint appointment as a cognitive neurologist at Mater Misericordiae Ltd (Mater Hospital).

His particular interests include understanding the earliest stages of Alzheimer's disease (i.e. before dementia is established); atypical forms of dementia with a particular focus on primary progressive aphasia and dementias related to Parkinson's and Lewy body diseases; and improving differential diagnosis between the major categories of neurodegenerative diseases.

He works on development of neuropsychological tests of cognition, both to accurately track change over time and improve diagnostic accuracy between the major diseases causing dementia. He also uses multi-modal imaging (magnetic resonance imaging [MRI] and positron emission tomography [PET]) to understand the sequence of events occurring in degenerative brain diseases (particularly Alzheimer's disease, frontotemporal dementia, Parkinson's disease, motor neuron disease [ALS], progressive supranuclear palsy [PSP] and corticobasal degeneration [CBD]) and identify novel biomarkers. A major focus of his is on developing novel approaches to MR imaging for single subject pathological diagnoses that can be exported into the everyday clinical setting; recent examples include diffusion tensor imaging to identify PSP and CBD (Sajjadi et al, 2013) and quantitative susceptibility mapping in Parkinson's disease (Acosta-Cabornero et al, 2013).

Professor Gail Robinson holds a joint Queensland Brain Institute and the School of Psychology appointment. She has been a clinical neuropsychologist and researcher for ~25 years in Australia and in London (UK), where she spent 14 years at the dynamic and historic National Hospital of Neurology and Neurosurgery, Queen Square, London. In 2010, she transitioned from a clinical role to an academic position at The University of Queensland where was Director of the Clinical Neuropsychology Doctoral programme (2010-2018), taking up this lead role again in 2023. Her clinical research is focused on both theoretical questions about brain-behaviour relationships like the crucial mechanisms for the executive control of language, and clinical questions regarding cognitive assessment and management of various pathologies including neurodegenerative disorders, neurodevelopmental disorders, brain tumours and stroke. Professor Robinson has attracted internal and national funding; she Leads the Neuropsychology Core of a large-scale longitudinal and multidisciplinary NHMRC Dementia Team Research grant (Prospective Imaging Study of Ageing: Genes, Brain and Behaviour - PISA). She was the recipient of an ARC Discovery Early Career Researcher Award (DECRA) in 2012 and a NHMRC Boosting Dementia Research Leadership Fellowship in 2018 in which she has been focused on early neurocognitive diagnostic indicators for dementia.

Professor Pankaj Sah is Director of the Queensland Brain Institute (QBI) at The University of Queensland (UQ). He is renowned for his work in understanding the neural circuitry of the amygdala, an area of the brain that plays a central role in learning and memory formation. Dysfunction of the amygdala leads to a host of anxiety-related disorders. His laboratory uses a combination of molecular tools, electrophysiology, anatomical reconstruction, calcium imaging and behavioural studies to examine the electrophysiological signatures of different brain regions and their impact on disease. Recently, his laboratory has been working with patients undergoing electrode implantation for deep brain stimulation, which is used to treat a variety of disorders such as Parkinson's disease, Tourette's syndrome and essential tremor. Professor Sah trained in medicine at The University of New South Wales and, after completing his internship, gained a PhD from the Australian National University. Following postdoctoral work at the University of California, San Francisco, and UQ, he established his own laboratory at the University of Newcastle in 1994. He then joined the John Curtin School of Medical Research at the Australian National University as a group leader in 1997. He was recruited to QBI as a founding member in 2003, and has been Director since July 2015. Professor Sah has published over 110 papers in international peer-reviewed journals. He is also the Editor-in-Chief of the Nature Partner Journal npj Science of Learning, the first journal to bring together the findings of neuroscientists, psychologists, and education researchers to understand how the brain learns.

Karen Thorpe is Australian Research Council, Laureate Professor and Group Leader in Child Development, Education and Care at the Queensland Brain Institute, University of Queensland. Her research is grounded in the understanding that early learning experiences shape brain development and are critical in establishing trajectories of health, social inclusion and learning across the lifespan. A particular focus of her work is early care and education environments including parenting, parent work, quality of care and education, and the early years workforce.

Karen leads a multi-disciplinary team of developmental scientists undertaking large scale longitudinal studies with embedded studies to explicate mechanisms that enable or limit children's life chances. She was Foundation Psychologist on the Avon Longitudinal Study of Parents and Children at the University of Bristol, UK; led the evaluation of the Preparing School Trial for Queensland Government; led the Queensland team of the E4Kids study of quality in Australian Early Education and Care and a recent data linkage project with Queensland Government to track participants through their school journey. In partnership with Queensland Government, Goodstart Early Learning and the Creche and Kindergarten Association she led a large population study of the Australian ECEC workforce (ARC Linkage). Her current research, as a chief investigator on the ARC Centre of Excellence for Children and Families across the life course, and through an ARC Laureate fellowship, is to examine barriers to providing high quality early learning services in developmentally vulnerable communities.

In 2013 and again in 2019 Karen was named by the Australian Financial Review as among Australia's 100 Women of Influence for the impacts of her research on educational and family policy. In 2020 she was recognised by Australian Government, Advance Global Awards for her international contribution to education. Karen chairs the Australian Early Years Reference Council for Evidence for Learning, Australia whose remit is to build a strong evidence-base in early childhood education and care with focus on translation into policy and practice. She is also director on the board of the Australian Research Council for Children and Youth and advisor to the national board of Beyond Blue – Be You.

Dr. Susannah Tye joined the Queensland Brain Institute in 2017 and has established a research program within the Asia Pacific Centre for Neuromodulation (QLD, Australia). Before returning to Australia, Dr. Tye directed the Translational Neuroscience Laboratory at the Mayo Clinic (2012-2017). While there she led efforts to develop brain stimulation devices (for rodents and humans) that can quantify neural activity and neurotransmitter dynamics in the living brain. This body of work now forms the basis of the neuropsychiatric arm of the Mayo Clinic’s Deep Brain Stimulation Consortium. Her specific research expertise are in utilising voltammetric (electrochemical) recording techniques to monitor rapid, synaptic neurotransmission in the living brain.

Dr. Tye has over ten years of experience studying neuromodulation in preclinical rodent models and human patients. Her long-term goal is to bridge preclinical and clinical studies to maximise translational impact, specifically in terms of improving patient outcomes for those with severe refractory psychiatric illness. Towards this end, she maintains many international collaborations with both clinical and basic science researchers. Dr. Tye also has a longstanding interest in mentoring young scientists to help them expand their skills in preclinical and basic science research and achieve a successful research career.

Associate Professor Bruno van Swinderen received his PhD in Evolutionary and Population Biology in 1998 from Washington University in St. Louis, Missouri. His graduate work was on general anesthesia in a Caenorhabditis elegans model, applying both quantitative genetics and molecular genetic approaches. For his postdoc at The Neurosciences Institute (NSI) in San Diego, California (1999-2003), he switched to Drosophila melanogaster to develop methods of studying perception in the fruit-fly model. He ran a lab at NSI from 2003 to late 2007.

In February 2008, Associate Professor van Swinderen established a new laboratory at the Queensland Brain Institute.

Bruno van Swinderen's group use Drosophila as a genetic model system to study mechanisms of perception in the brain abd are interested in three phenomena: selective attention, sleep, and general anesthesia. Their focus is on visual perception and how it is affected by these different arousal states. Most of our current effort is in understanding visual selective attention in the fly brain and how attention processes interact with memory formation. Toward this goal, they use various novel visual paradigms in a Drosophila molecular genetics context.

The Vukovic laboratory investigates how brain function is sculpted and influenced by the immune system. Specifically, we examine the role of brain's main resident immune cell population (i.e. microglia), as well as various peripheral immune cells, on learning and memory in mice. We are interested in defining the contribution of immune cells to such higher cognitive tasks, including for neuroinflammatory conditions where learning and memory deficits can occur, e.g. following traumatic brain injury, cancer treatment, and ageing. We have established an array of genetic and pharmacological tools alongside robust behavioural assays to directly probe the function of these immune cells in both the healthy and diseased brain. The ultimate goal of our work is to link cellular and molecular events to altered behaviour, and to harness the brain's intrinsic regenerative potential for stimulating optimal cognitive function.

A neuroimmunologist, Dr Vukovic received her PhD in 2008 from The University of Western Australia after working on the repair of injured nerve cell connections. She joined QBI in 2009 to work in Professor Perry Bartlett's laboratory as a Postdoctoral Research Fellow, before being awarded a Queensland Government Smart Futures Fellowship to continue her research into the importance of adult neurogenesis for behaviour and how microglia influence this process in ageing. Dr Vukovic demonstrated that microglia can exert a dual and opposing influence over adult neurogenesis (the birth of new neurons) in the hippocampus under different physiological conditions, namely exercise and ageing, and that signalling through the chemokine receptor, CX3CR1, critically contributes towards this (Vukovic et al., 2012, J Neurosci). Dr Vukovic also generated novel evidence that ongoing neurogenesis in the adult hippocampus is critical for new learning but does not play a role in memory recall (Vukovic et al., 2013, J Neurosci).

Dr Vukovic was awarded an ARC Discovery Early Career Researcher Award (2015-2018) and was jointly appointed as a group leader by the UQ School of Biomedical Sciences (SBMS) and QBI in 2015. She heads the Neuroimmunology and Cognition team investigating the interactions between the brain and the immune system in health and disease.

Currently, the group is working on three main projects:

1. Identification of microglia-derived molecules that support neuronal survival and stimulate neural stem/progenitor cell expansion
2. Characterisation of immune cell contribution to changes in neuronal connectivity
3. Immune cell responses to cancer treatment, and their effect on learning and memory

Dr Adam Walker received his BSc(Hons) in Biochemistry from the University of Tasmania, and PhD in Neuroscience from the Florey Institute of Neuroscience and Mental Health at the University of Melbourne, focused on understanding the molecular mechanisms of motor neuron disease (MND). He undertook a postdoctoral fellowship with Professor Virginia Lee at the Center for Neurodegenerative Disease Research, University of Pennsylvania (2011-2015), developing new transgenic TDP-43 mouse models of disease. Dr Walker was previously an NHMRC CJ Martin Overseas Biomedical Research Fellow and was awarded an NHMRC RD Wright Career Development Fellowship (2018-2022), to continue his research on neurodegenerative diseases. His research has been supported by fellowships and project grants from the Australian National Health and Medical Research Council, the Australian National Foundation for Medical Research and Innovation, Dementia Australia, Motor Neuron Disease Research Institute of Australia, MonSTaR Foundation and the Cure for MND Foundation.

Dr Tara Walker is a Senior Research Associate at the Queensland Brain Institute. Dr Walker's group is investigating the mechanisms governing the lifelong production of neurons in the adult brain (adult neurogenesis). Tara studied Biotechnology as an undergraduate at the Queensland University of Technology (Brisbane, Australia), before carrying out her PhD in the field of Plant Biotechnology. In 2003 she made the transition to neuroscience, joining the Queensland Brain Institute (QBI) and the group of Professor Perry Bartlett. Here she became interested in the field of adult hippocampal neurogenesis, particularly in its activity-dependent regulation. In 2010, she joined the group of Professor Gerd Kempermann at the Center for Regenerative Therapies in Dresden, Germany, where she was awarded a Marie Curie International Incoming Fellowship in 2011. In July 2018 she returned to QBI to take up a position in the newly developed Centre for Restorative Neurosciences as a Senior Research Associate, where she will apply her knowledge of neural stem cell biology to stroke research.

Naomi Wray is the Michael Davys Professor in the Department of Psychiatry, University of Oxford. She holds an appointment at the Institute for Molecular Bioscience (IMB) within the University of Queensland. She joined UQ Queensland Brain Institute in 2011 moving to the IMB in 2015. She was Head of the Centre for Population & Disease Genomics within IMB 2018-2023. Her Oxford appointment started in 2023.

Her research focuses on development and application of quantitative genetics and genomics methodologies across complex diseases, disorders and traits, but particularly psychiatric-related traits.

She is a National Health and Medical Research Council (NHMRC) Leadership Fellow, a Fellow of the Australian Academy of Science and a Fellow of the Australian Academy of Health and Medical Science. In 2020 she was awarded the NHMRC Elizabeth Blackburn Award for Leadership in Basic Science and the 2021 International Society of Psychiatric Genetics Ming Tsuang Lifetime Achievement Award. She is a Clarivate Highly Cited researcher.

She was Director of the Program in Complex Trait Genomics (PCTG) funded as an NHMRC Program Grant 2017-2022. She plays a key role in the International Psychiatric Genomics Consortium and established the sporadic ALS Australia systems genomics consortium (SALSA) funded by the MND Research Australia IceBucket Challenge and FightMND. She is a co-investigator on the Australian Genetics of Depression Study (AGDS) and is currently launching the AGDS-Cello project focussed on establishing a cell line resource from participants with a detailed history of anti-depressant use and response measures. She is part of an NHMRC Synergy (2023-2027) "Rhythms and blues: Personalising care for body clock dysfunction in mood disorders".

She is secretary of the International Society of Psychiatric Genetics, and is on the editorial advisory boards of JAMA Psychiatry, Neuron, Royal Society Open and Research Directions: Depression.

Dr Steven Zuryn is a molecular geneticist within the Queensland Brain Institute, The University of Queensland. After training as a PhD in genetics, he undertook postdoctoral reseach at the Institut Génétique Biologie Moléculaire Cellulaire (IGBMC) in Strasbourg, France. He now leads an international and diverse team of postdoctoral, PhD, Honours, and undergraduate investigators studying epigenetics and mitochondrial biology. His laboratory's work focuses on the role and impact of mitochondrial dysfunction in neurodegenerative diseases and is particularly fascinated with mutations that accumulate within the mitochondria's own genome during ageing. His research has been published in the high profile journals Science, Nature Cell Biology, and Nature Communications and has appeared in multiple mainstream media outlets. For his research, he has received multiple international prizes and fellowships, been awarded grants from the NHMRC and ARC as primary chief investigator and is generously supported as a fellow of the Stafford Fox Research Foundation. Steven is passionate about communicating the critical importance of fundamental scientific research as a long-term human endeavour.

Follow the Zuryn lab on Twitter: @zurynlab

Visit the Zuryn lab website.